RecruitingNCT05847387

The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study

Preoperative Surgeon Evaluation of Corneal Endothelial Status: the Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study


Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Enrollment

135 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this international cohort study is to validate a new method for preoperative assessment of endothelial viability in donor corneal tissues for transplantation, and to correlate endothelial health as assessed by the surgical team to functional and structural long-term outcomes in the cohort of patients receiving them.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age older than 18 years old
  • Planned corneal transplantation: perforating keratoplasty (PK), Descemet stripping automated endothelial keratoplasty (DSAEK), ultra-thin DSAEK (UT-DSAEK) or Descemet membrane endothelial keratoplasty (DMEK)
  • Indication for corneal transplantation (low-moderate risk of rejection): keratoconus, Fuchs endothelial dystrophy
  • Ability to provide written informed consent.

Exclusion Criteria9

  • Prior corneal transplantation
  • Planned preloaded DSAEK or preloaded DMEK
  • Planned keratoplasty not involving corneal endothelium transplantation (i.e., superficial/deep anterior lamellar keratoplasty)
  • Evidence of concurrent microbial keratitis
  • Evidence of non-infectious or autoimmune keratitis
  • Impending or frank corneal perforation
  • Uncontrolled, elevated intraocular pressure (IOP)- Previous glaucoma surgery
  • Acute or chronic inflammatory/infectious anterior segment uveitis
  • Presence of an anterior chamber intraocular lens (IOL) for phakic or aphakic purposes

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTV-Check

Preoperative analysis of endothelial tissue staining with vital dye (Trypan Blue 0.05%) and image analysis to identify the percentage of Trypan Blue Positive Areas, corresponding to dead endothelial cells and/or denuded areas of endothelium, in tissues destined to keratoplasty


Locations(12)

Antwerp University Hospital

Edegem, Belgium

Department of Ophthalmology, University of Cologne

Cologne, Germany

Münster University Hospital

Münster, Germany

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Brescia, BS, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

Department of Medical and Surgical Sciences, University Magna Græcia

Catanzaro, Italy

Department of Experimental Medicine, Tor Vergata School of Medicine and Surgery

Roma, Italy

Fondazione Banca degli Occhi del Veneto

Venice, Italy

San Bortolo Hospital

Vicenza, Italy

Maastricht University Medical Center

Maastricht, Netherlands

Hospital Regional Universitario de Málaga

Málaga, Spain

Royal Liverpool University Hospital

Liverpool, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05847387


Related Trials